Anika Therapeutics Inc
$ 21.42
6.25%
07 Aug - close price
- Market Cap 286,663,000 USD
- Current Price $ 21.42
- High / Low $ 21.55 / 20.09
- Stock P/E N/A
- Book Value 10.26
- EPS -0.23
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.01 %
- ROE -0.02 %
- 52 Week High 21.55
- 52 Week Low 8.15
About
Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts.
Analyst Target Price
$21.00
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-07-29 | 2026-04-29 | 2026-02-26 | 2025-11-05 | 2025-07-30 | 2025-05-09 | 2025-03-12 | 2024-10-31 | 2024-08-08 | 2024-05-08 | 2024-03-13 | 2023-11-02 |
| Reported EPS | 0.3 | 0.27 | 0.13 | -0.17 | -0.13 | -0.06 | -0.14 | -0.25 | 0.17 | 0.09 | -4.3 | -0.45 |
| Estimated EPS | -0.19 | -0.16 | -0.19 | -0.19 | -0.13 | 0.09 | -0.11 | 0.3 | 0.2 | 0.05 | -0.26 | -0.35 |
| Surprise | 0.49 | 0.43 | 0.32 | 0.02 | 0 | -0.15 | -0.03 | -0.55 | -0.03 | 0.04 | -4.04 | -0.1 |
| Surprise Percentage | 257.8947% | 268.75% | 168.4211% | 10.5263% | 0% | -166.6667% | -27.2727% | -183.3333% | -15% | 80% | -1553.8462% | -28.5714% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ANIK
2026-08-08 22:16:02
This article analyzes Anika Therapeutics Inc. (ANIK) using AI models, highlighting strong sentiment across all horizons and significant upside potential due to the absence of resistance levels above the current price. It presents three distinct institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, alongside a multi-timeframe signal analysis. The report emphasizes the role of AI in providing real-time signals, risk management, and personalized alerts for investors.
2026-08-08 05:39:35
This Yahoo Finance page provides comprehensive financial data for Anika Therapeutics, Inc. (ANIK), a company specializing in early intervention orthopedics. It includes current stock price, performance metrics, key statistics, earnings trends, analyst ratings, and a company overview detailing its product offerings in osteoarthritis pain management and regenerative solutions. The stock closed at $21.42, up 6.25%, with strong year-to-date and 1-year returns.
2026-08-08 02:11:52
This Yahoo Finance page provides comprehensive financial information for Anika Therapeutics, Inc. (ANIK), including its current stock price, recent news, historical data, and analyst insights. The company, which specializes in early intervention orthopedics, shows a positive short-term stock performance but a significant decline over five years. Key financial metrics, earnings trends, and a company overview are also detailed.
2026-08-07 22:10:36
This article provides comprehensive financial data for Anika Therapeutics, Inc. (ANIK), including its current stock price, historical performance, and key financial metrics. It details the company's orthopedic products and services, analyst ratings, and comparative data with other companies in the drug manufacturing industry. The information aims to offer investors a detailed overview of ANIK's market position and financial health.
2026-08-07 21:10:36
An individual holder of Anika Therapeutics, Inc. (ANIK) plans to sell 16,864 shares of common stock on NASDAQ, with an aggregate market value of $355,255.47 as of August 7, 2026, according to a Form 144 filing. The filing also notes recent activity including an issuer open market purchase of 2,700 shares on March 5, 2024, and restricted stock vesting of 14,164 shares on June 20, 2026. This transaction provides transparency regarding the proposed sale of restricted securities.
2026-08-07 16:10:36
Anika Therapeutics Inc (ANIK) has an earnings forecast score of 9.00, placing it 7th in the Healthcare Equipment & Supplies industry. Analysts have a consensus "Strong Buy" rating with an average price target of $16.00. The company's expected revenue for the next quarter is $29.74 million, and the EPS for the next quarter is projected at $0.04.
